About This Course

Managing chemotherapy-induced neutropenia in 2021 - get the latest updates to improve treatment adherence, increase patient access, and reduce clinic visits during the COVID-19 pandemic.

An interactive course aimed at healthcare professionals (oncologists, general practitioners, nurse practitioners) treating cancer patients receiving chemotherapy.

This course should take you approximately 60 minutes to complete.

Lee Schwartzberg, MD FACP
West Cancer Center, Germantown, TN, USA

Adam Brufsky, MD PhD
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA

Kashyap B Patel, MD
Carolina Blood and Cancer Care Associates, Rock Hill, SC, USA

This course has a 2-year expiry date of 15th May. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.

Learning Objectives

By the end of this module, you should:

  • Understand the definition of febrile neutropenia in patients receiving chemotherapy

  • Appreciate the impact both for the patient and the health system

  • Be familiar with risk assessment for the development of serious complications

  • Know the treatment options

Course curriculum

    1. Welcome to the Course

    1. Navigation Instructions

    1. Take this quiz before you start

    2. Pre-Course Quiz

    1. Main Course

    1. Introduction to Final Quiz

    2. Now check how much you have learned.

    1. Download the summary sheet

    1. Course Feedback Survey

About this course

  • Free
  • 9 lessons
  • 0 hours of video content

Commercial Support

This activity is supported by an educational grant from Fresenius Kabi SwissBioSim GmbH.